Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database.
Journal: Health and social care delivery research
Published: August 28, 2026
Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.
Journal: Cancer medicine
Published: January 27, 2025
Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications.
Journal: Expert opinion on investigational drugs
Published: November 16, 2023
A randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: September 18, 2022
Recent Progress in the Development of Opaganib for the Treatment of Covid-19.
Journal: Drug design, development and therapy
Published: March 25, 2022
Reply to Black and Ford.
Journal: The American journal of gastroenterology
Published: October 28, 2020
Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial.
Journal: The American journal of gastroenterology
Published: July 09, 2020
Absence of QT prolongation after administration of a 24-mg bimodal-release ondansetron pill (RHB-102).
Journal: The American journal of emergency medicine
Published: December 07, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026